Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Zamboni WC, Torchilin V, Patri AK, Hrkach J, Stern S, Lee R, Nel A, Panaro NJ, Grodzinski P.

Clin Cancer Res. 2012 Jun 15;18(12):3229-41. doi: 10.1158/1078-0432.CCR-11-2938. Epub 2012 Jun 5. Review.

2.

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.

Piktel E, Niemirowicz K, Wątek M, Wollny T, Deptuła P, Bucki R.

J Nanobiotechnology. 2016 May 26;14(1):39. doi: 10.1186/s12951-016-0193-x. Review.

3.

Highlights of recent developments and trends in cancer nanotechnology research--view from NCI Alliance for Nanotechnology in Cancer.

Hull LC, Farrell D, Grodzinski P.

Biotechnol Adv. 2014 Jul-Aug;32(4):666-78. doi: 10.1016/j.biotechadv.2013.08.003. Epub 2013 Aug 12. Review.

PMID:
23948249
4.

Design considerations for nanotherapeutics in oncology.

Stylianopoulos T, Jain RK.

Nanomedicine. 2015 Nov;11(8):1893-907. doi: 10.1016/j.nano.2015.07.015. Epub 2015 Aug 15. Review.

5.

Recent progress in nanotechnology for cancer therapy.

Tang MF, Lei L, Guo SR, Huang WL.

Chin J Cancer. 2010 Sep;29(9):775-80. Review.

6.

Lipid nanoparticles for cancer therapy: state of the art and future prospects.

Lasa-Saracibar B, Estella-Hermoso de Mendoza A, Guada M, Dios-Vieitez C, Blanco-Prieto MJ.

Expert Opin Drug Deliv. 2012 Oct;9(10):1245-61. Epub 2012 Sep 5. Review.

PMID:
22950878
7.

A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.

Steichen SD, Caldorera-Moore M, Peppas NA.

Eur J Pharm Sci. 2013 Feb 14;48(3):416-27. doi: 10.1016/j.ejps.2012.12.006. Epub 2012 Dec 20. Review.

8.

Clinical developments in nanotechnology for cancer therapy.

Heidel JD, Davis ME.

Pharm Res. 2011 Feb;28(2):187-99. doi: 10.1007/s11095-010-0178-7. Epub 2010 Jun 12. Review.

PMID:
20549313
9.

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Kateb B, Chiu K, Black KL, Yamamoto V, Khalsa B, Ljubimova JY, Ding H, Patil R, Portilla-Arias JA, Modo M, Moore DF, Farahani K, Okun MS, Prakash N, Neman J, Ahdoot D, Grundfest W, Nikzad S, Heiss JD.

Neuroimage. 2011 Jan;54 Suppl 1:S106-24. doi: 10.1016/j.neuroimage.2010.01.105. Epub 2010 Feb 10. Review.

10.

Supramolecular nanoscale assemblies for cancer diagnosis and therapy.

Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MA.

J Control Release. 2015 Sep 10;213:152-67. doi: 10.1016/j.jconrel.2015.06.034. Epub 2015 Jul 6. Review.

PMID:
26160308
11.

Polymeric nanoparticles for cancer therapy.

Parveen S, Sahoo SK.

J Drug Target. 2008 Feb;16(2):108-23. doi: 10.1080/10611860701794353 . Review.

PMID:
18274932
12.

Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.

Dobrovolskaia MA, McNeil SE.

Expert Opin Drug Deliv. 2015 Jul;12(7):1163-75. doi: 10.1517/17425247.2015.1042857. Epub 2015 May 20. Review.

PMID:
25994601
13.

Nanoparticle therapeutics: Technologies and methods for overcoming cancer.

Cerqueira BB, Lasham A, Shelling AN, Al-Kassas R.

Eur J Pharm Biopharm. 2015 Nov;97(Pt A):140-51. doi: 10.1016/j.ejpb.2015.10.007. Epub 2015 Oct 26. Review.

PMID:
26515260
14.

Nanotechnology applied to overcome tumor drug resistance.

Gao Z, Zhang L, Sun Y.

J Control Release. 2012 Aug 20;162(1):45-55. doi: 10.1016/j.jconrel.2012.05.051. Epub 2012 Jun 12. Review.

PMID:
22698943
15.

Nanoparticles in oncology: the new theragnostic molecules.

Allegra A, Penna G, Alonci A, Rizzo V, Russo S, Musolino C.

Anticancer Agents Med Chem. 2011 Sep;11(7):669-86. Review.

PMID:
21787275
16.

Nanometric gold in cancer nanotechnology: current status and future prospect.

Ahmad MZ, Akhter S, Rahman Z, Akhter S, Anwar M, Mallik N, Ahmad FJ.

J Pharm Pharmacol. 2013 May;65(5):634-51. doi: 10.1111/jphp.12017. Epub 2012 Dec 24. Review.

PMID:
23600380
17.

Nanoparticle-based targeted drug delivery.

Singh R, Lillard JW Jr.

Exp Mol Pathol. 2009 Jun;86(3):215-23. doi: 10.1016/j.yexmp.2008.12.004. Epub 2009 Jan 7. Review.

18.

Use of nanoparticles for drug delivery in glioblastoma multiforme.

Jain KK.

Expert Rev Neurother. 2007 Apr;7(4):363-72. Review.

PMID:
17425491
19.

Nanoparticles for delivery of chemotherapeutic agents to tumors.

Vijayaraghavalu S, Raghavan D, Labhasetwar V.

Curr Opin Investig Drugs. 2007 Jun;8(6):477-84. Review.

PMID:
17621878
20.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Review.

PMID:
25813885

Supplemental Content

Support Center